Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07010614

Brain Stimulation to the Hippocampus in Schizophrenia

Theta Burst Modulation of Hippocampal-Cortical Rhythms in Schizophrenia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizophrenia symptoms, but to develop better therapies we need to understand whether hippocampal activity in schizophrenia can be systematically affected by non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). This proposal will investigate the use of connectivity-guided theta burst brain stimulation to specifically target hippocampal function in schizophrenia, offering insights into fundamental hippocampal processes, schizophrenia pathophysiology, and potential avenues to use brain stimulation as a therapeutic tool in this devastating illness.

Conditions

Interventions

TypeNameDescription
DEVICEIntracranial electrodesIntracranial electrodes will be used for the delivery of invasive electrical brain stimulation.
DEVICETMSTMS will be used for the delivery of noninvasive brain stimulation
DEVICETMS shamSham TMS will be used as a comparator for noninvasive brain stimulation

Timeline

Start date
2025-10-01
Primary completion
2027-09-30
Completion
2027-09-30
First posted
2025-06-08
Last updated
2026-02-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07010614. Inclusion in this directory is not an endorsement.